Key result
Obstructive sleep apnea syndrome was not associated with an increased risk of incident diabetic retinopathy in patients with type 2 diabetes.
Why the study?
Whether obstructive sleep apnea syndrome increases the risk of diabetic retinopathy remains uncertain.
Does obstructive sleep apnea syndrome increase the risk of incident diabetic retinopathy in patients with type 2 diabetes?
Meta-Analysis (n=599,405)
Does obstructive sleep apnea syndrome increase the risk of incident diabetic retinopathy in patients with type 2 diabetes?
Answers are grounded in this paper and cite their sources.
Current cohort evidence does not support a significant overall association between OSAS and the risk of incident diabetic retinopathy in patients with type 2 diabetes, though associations were observed in Asian populations and studies using objective sleep assessments.
Background: Obstructive sleep apnea syndrome (OSAS) has been implicated in the development of diabetic microvascular complications through intermittent hypoxia, oxidative stress, and endothelial dysfunction. However, whether OSAS increases the risk of diabetic retinopathy (DR) remains uncertain. This meta-analysis aimed to evaluate the longitudinal association between OSAS and the risk of incident DR in patients with diabetes. Methods: PubMed, Embase, Web of Science, Wanfang Data, and China National Knowledge Infrastructure were searched from inception to April 13, 2026. Prospective and retrospective cohort studies evaluating the association between OSAS and incident DR were included. Risk ratios (RRs) and 95% confidence intervals (CI) were pooled using a random-effects model. Prespecified subgroup, sensitivity, and meta-regression analyses were performed. Results: values all > 0.05). Subgroup analyses suggested a significant association in studies from Asian countries (RR: 2.37, 95% CI: 1.09 to 5.15) and in studies using polysomnography or home-based sleep testing for OSAS diagnosis (RR: 2.46, 95% CI: 1.42 to 4.27), whereas no significant association was observed in Western studies or studies using administrative database codes. No significant differences were identified between subgroups according to study design, mean age, follow-up duration, DR ascertainment method, or adjustment for baseline HbA1c and diabetes duration. Meta-regression analyses did not identify significant moderators of the association. Conclusions: Current cohort evidence does not support a significant overall association between OSAS and the risk of incident DR in patients with T2D. However, significant associations observed in Asian populations and studies using objective sleep assessments suggest that the relationship may vary according to population characteristics and diagnostic methodology. Further well-designed prospective studies are warranted. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD420261428206.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) conducted a meta-analysis in Type 2 diabetes (n=599,405). Obstructive sleep apnea syndrome (OSAS) vs. Participants without OSAS was evaluated on Incident diabetic retinopathy (RR 1.09, 95% CI 0.90 to 1.31, p=0.38). Obstructive sleep apnea syndrome was not associated with an increased risk of incident diabetic retinopathy in patients with type 2 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: